[Antirabies vaccination with a vaccine consisting of virus cultivated in human diploid cells]. 1982

R Trivello, and V Gasparini, and F Marcati, and M E Moschen, and G Renzulli, and S Rocco, and F Canova, and G Rausa

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011818 Rabies Acute VIRAL CNS INFECTION affecting mammals, including humans. It is caused by RABIES VIRUS and usually spread by contamination with virus-laden saliva of bites inflicted by rabid animals. Important animal vectors include the dog, cat, bat, fox, raccoon, skunk, and wolf. Encephalitic Rabies,Furious Rabies,Hydrophobia,Paralytic Rabies,Lyssa,Furious Raby,Lyssas,Rabies, Encephalitic,Rabies, Furious,Raby, Furious
D011819 Rabies Vaccines Vaccines or candidate vaccines used to prevent and treat RABIES. The inactivated virus vaccine is used for preexposure immunization to persons at high risk of exposure, and in conjunction with rabies immunoglobulin, for postexposure prophylaxis. Rabies Human Diploid Cell Vaccine,Rabies Vaccine,Vaccine, Rabies,Vaccines, Rabies
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D002675 Child, Preschool A child between the ages of 2 and 5. Children, Preschool,Preschool Child,Preschool Children
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

R Trivello, and V Gasparini, and F Marcati, and M E Moschen, and G Renzulli, and S Rocco, and F Canova, and G Rausa
January 1983, Giornale di batteriologia, virologia ed immunologia,
R Trivello, and V Gasparini, and F Marcati, and M E Moschen, and G Renzulli, and S Rocco, and F Canova, and G Rausa
February 1990, Casopis lekaru ceskych,
R Trivello, and V Gasparini, and F Marcati, and M E Moschen, and G Renzulli, and S Rocco, and F Canova, and G Rausa
January 1982, Medicinski pregled,
R Trivello, and V Gasparini, and F Marcati, and M E Moschen, and G Renzulli, and S Rocco, and F Canova, and G Rausa
December 1980, JAMA,
R Trivello, and V Gasparini, and F Marcati, and M E Moschen, and G Renzulli, and S Rocco, and F Canova, and G Rausa
June 1991, Presse medicale (Paris, France : 1983),
R Trivello, and V Gasparini, and F Marcati, and M E Moschen, and G Renzulli, and S Rocco, and F Canova, and G Rausa
January 1978, Developments in biological standardization,
R Trivello, and V Gasparini, and F Marcati, and M E Moschen, and G Renzulli, and S Rocco, and F Canova, and G Rausa
March 1984, The Journal of communicable diseases,
R Trivello, and V Gasparini, and F Marcati, and M E Moschen, and G Renzulli, and S Rocco, and F Canova, and G Rausa
November 1981, JAMA,
R Trivello, and V Gasparini, and F Marcati, and M E Moschen, and G Renzulli, and S Rocco, and F Canova, and G Rausa
January 1978, Developments in biological standardization,
R Trivello, and V Gasparini, and F Marcati, and M E Moschen, and G Renzulli, and S Rocco, and F Canova, and G Rausa
November 1994, Presse medicale (Paris, France : 1983),
Copied contents to your clipboard!